TAP top app download banner
theAsianparent
theAsianparent
Product Guide
  • Together Against RSV
  • Pregnancy
  • Parenting
  • Child
  • Feeding & Nutrition
  • Education
  • Lifestyle
  • Events
  • Holiday Hub
  • Aptamil
  • TAP Recommends
  • Shopping
  • Press Releases
  • Project Sidekicks
  • Community
  • Advertise With Us
  • Contact Us
  • VIP
Login
    • Articles
  • Together Against RSVTogether Against RSV
  • PregnancyPregnancy
  • ParentingParenting
  • ChildChild
  • Feeding & NutritionFeeding & Nutrition
  • EducationEducation
  • LifestyleLifestyle
  • EventsEvents
  • Holiday HubHoliday Hub
  • AptamilAptamil
  • TAP RecommendsTAP Recommends
  • ShoppingShopping
  • Press ReleasesPress Releases
  • Project SidekicksProject Sidekicks
  • CommunityCommunity
  • Advertise With UsAdvertise With Us
  • Contact UsContact Us
  • VIPVIP
    • Community
  • Poll
  • Photos
  • Food
  • Recipes
  • Topics
  • Read Articles
    • Tracker
  • Pregnancy Tracker
  • Baby Tracker
    • Rewards
  • RewardsRewards
  • Contests
  • VIP ParentsVIP Parents
    • More
  • Feedback

Privacy PolicyCommunity GuidelinesSitemap HTML

Download our free app

google play store
app store

AI System to Be Trialled at Three Singapore Hospitals for Faster Coronary Artery Disease (CAD) Detection

3 min read
AI System to Be Trialled at Three Singapore Hospitals for Faster Coronary Artery Disease (CAD) Detection

In a major step forward for cardiovascular healthcare, an artificial intelligence (AI) system called the Singapore Heart Lesion Analyzer (Sense) is scheduled to undergo a year-long clinical trial starting in the third quarter of 2025. This pilot programme will take place at three of the nation’s leading medical institutions: National Heart Centre Singapore (NHCS), National University Hospital (NUH), and Tan Tock Seng Hospital (TTSH).

Transforming Diagnosis with Speed and Precision

Sense is designed to transform the detection of coronary artery disease (CAD), the leading cause of heart-related deaths in Singapore. Unlike traditional methods, which can take two to four hours for a scan analysis, Sense aims to deliver results in under ten minutes. This dramatic improvement in speed has the potential to reduce waiting times, speed up treatment decisions, and ultimately save lives.

In controlled environments, Sense has achieved accuracy rates between 85 and 99 per cent. The upcoming trial will assess whether the system can maintain such performance in real-world clinical settings.

How Sense Works: Behind the Technology

The Sense AI system analyses CT scans using deep learning algorithms that measure several key indicators of heart disease, including:

  • Coronary calcium levels

  • Fat deposits around the heart (epicardial adipose tissue)

  • Degree of artery narrowing (stenosis)

  • Types and sizes of plaque formations

These metrics are processed into a detailed yet easy-to-understand risk report for doctors to review, significantly reducing the time needed for interpretation without compromising diagnostic integrity.

Trial Design and Patient Participation

The clinical trial will involve approximately 300 patients across the three hospitals. Over a 12-month period, the trial will measure how well Sense performs under routine hospital conditions.

While the system speeds up analysis, it is important to note that clinical decision-making remains the responsibility of physicians. The AI acts as a support tool, not a replacement for medical expertise.

Built on a National Imaging Database

Sense was developed by the CardioVascular Systems Imaging and AI (CVS.AI) lab at NHCS, in collaboration with researchers from A*STAR. The system is powered by a national CT coronary angiography database called APOLLO, which comprises more than three million images from around five thousand patients.

The CVS.AI lab now operates from a 164-square-metre facility equipped with advanced computing hardware, enabling rapid image processing and further development of AI healthcare solutions.

Addressing a National Health Crisis

Coronary artery disease remains a leading cause of death in Singapore, responsible for more than 8,300 cardiovascular-related fatalities in 2023 alone. Early detection is critical to improving outcomes, and AI tools like Sense could significantly enhance the speed and accuracy of diagnoses.

Globally, over 250 million people suffer from CAD, and the disease accounted for nearly nine million deaths in 2021. Singapore’s investment in AI technology reflects a proactive approach to combatting this global challenge.

National and Global Implications

  • Healthcare efficiency: Sense could free up clinical resources and reduce bottlenecks in patient diagnosis.

  • Standardised assessments: AI can ensure consistent evaluations across hospitals and reduce human variability.

  • Early intervention: Faster analysis allows for quicker treatment, potentially reducing long-term healthcare costs and improving survival rates.

Partner Stories
YouTrip Gives Away 100 Flights to Korea as  South Korea’s Popularity Takes Off Across Generations
YouTrip Gives Away 100 Flights to Korea as South Korea’s Popularity Takes Off Across Generations
Students Bring Forgotten Heritage to Life through Temasek Foundation-NUS Libraries Programme
Students Bring Forgotten Heritage to Life through Temasek Foundation-NUS Libraries Programme
The Secret to Raising an Adventurous Eater? More Variety, Not More Cooking.
The Secret to Raising an Adventurous Eater? More Variety, Not More Cooking.
Takashimaya Unveils Singapore’s Largest Mid-Autumn Showcase with 61 Local and Global Brands
Takashimaya Unveils Singapore’s Largest Mid-Autumn Showcase with 61 Local and Global Brands

Got a parenting concern? Read articles or ask away and get instant answers on our app. Download theAsianparent Community on iOS or Android now!

img
Written by

Gio Adriano

  • Home
  • /
  • Health
  • /
  • AI System to Be Trialled at Three Singapore Hospitals for Faster Coronary Artery Disease (CAD) Detection
Share:
  • YouTrip Gives Away 100 Flights to Korea as  South Korea’s Popularity Takes Off Across Generations
    Partner Stories

    YouTrip Gives Away 100 Flights to Korea as South Korea’s Popularity Takes Off Across Generations

  • New WhatsApp Parental Controls for Teens: What Parents Can Now Manage

    New WhatsApp Parental Controls for Teens: What Parents Can Now Manage

  • Students Bring Forgotten Heritage to Life through Temasek Foundation-NUS Libraries Programme
    Partner Stories

    Students Bring Forgotten Heritage to Life through Temasek Foundation-NUS Libraries Programme

  • YouTrip Gives Away 100 Flights to Korea as  South Korea’s Popularity Takes Off Across Generations
    Partner Stories

    YouTrip Gives Away 100 Flights to Korea as South Korea’s Popularity Takes Off Across Generations

  • New WhatsApp Parental Controls for Teens: What Parents Can Now Manage

    New WhatsApp Parental Controls for Teens: What Parents Can Now Manage

  • Students Bring Forgotten Heritage to Life through Temasek Foundation-NUS Libraries Programme
    Partner Stories

    Students Bring Forgotten Heritage to Life through Temasek Foundation-NUS Libraries Programme

Feed

Feed

Get tailored articles about parenting, lifestyle, expert opinions right at your fingertips

Poll

Poll

Participate in interesting polls and see what other parents think!

Photos

Photos

Share the photos of loved ones in a safe, secure manner.

Topics

Topics

Join communities to bond with fellow mums and dads.

Tracker

Tracker

Track your pregnancy as well as baby’s development day-by-day!

theAsianparent

Download our free app

Google PlayApp Store

Mums around the world

Singapore flag
Singapore
Thailand flag
Thailand
Indonesia flag
Indonesia
Philippines flag
Philippines
Malaysia flag
Malaysia
Vietnam flag
Vietnam
India flag
India

Partner Brands

99.coVIP ParentsMama's ChoiceLittle ReiMothersworkTAP Awards

© Copyright theAsianparent 2026 . All rights reserved

  • About Us
  • Privacy Policy
  • Terms of Use
  • Sitemap HTML
  • Advertise With Us
  • Tools
  • Articles
  • Feed
  • Poll

We use cookies to ensure you get the best experience. Learn MoreOk, Got it

We use cookies to ensure you get the best experience. Learn MoreOk, Got it